C McLeod
Impact in
- Emergency Medical Services top 5%
- Central Venous Catheters and Hemodialysis
- Otorhinolaryngology top 10%
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 6
- Surgery 5
- Coronary Interventions and Diagnostics 3
- Co-authors
- Y Dündar (21 shared papers)Angela Boland (21 shared papers)A Bagust (21 shared papers)Rumona Dickson (18 shared papers)T Walley (12 shared papers)Nigel Fleeman (12 shared papers)J Greenhalgh (10 shared papers)Ruaraidh Hill (3 shared papers)
- Journals
- Health Technology Assessment (19 papers)Journal of Clinical Apheresis (2 papers)PharmacoEconomics (2 papers)Primary Health Care Research & Development (1 paper)The Pharmacogenomics Journal (1 paper)
- Partner nations
- United KingdomUnited StatesQatar
In The Last Decade
C McLeod
26 papers receiving 799 citations
Peers
Comparison fields: 5 of 84
- Emergency Medical Services 65
- Otorhinolaryngology 39
- Pharmacology 83
- Rheumatology 92
- Hematology 65
Countries citing papers authored by C McLeod
This map shows the geographic impact of C McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C McLeod more than expected).
Fields of papers citing papers by C McLeod
This network shows the impact of papers produced by C McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C McLeod. The network helps show where C McLeod may publish in the future.
Co-authors
The 25 scholars most cited alongside C McLeod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 141 | |
| 2 | 2010 | 88 | |
| 3 | 2008 | 79 | |
| 4 | 2010 | 53 | |
| 5 | 2007 | 48 | |
| 6 | 2009 | 48 | |
| 7 | 2006 | 46 | |
| 8 | 2009 | 46 | |
| 9 | 2009 | 38 | |
| 10 | 2009 | 37 | |
| 11 | 2010 | 36 | |
| 12 | 2010 | 26 | |
| 13 | 2010 | 25 | |
| 14 | 2010 | 16 | |
| 15 | 2007 | 16 | |
| 16 | 2014 | 15 | |
| 17 | 2009 | 12 | |
| 18 | 2015 | 11 | |
| 19 | 2010 | 10 | |
| 20 | Plerixafor is cost‐effective compared to conventional chemotherapy for first‐line haematopoietic stem cell mobilization: Data from the PHANTASTIC trial | 2015 | 8 |
About C McLeod
C McLeod is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Otorhinolaryngology and Genetics, having authored 27 papers that have together received 833 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (6 papers), Head and Neck Cancer Studies (3 papers), Cancer Genomics and Diagnostics (3 papers), Coronary Interventions and Diagnostics (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Central Venous Catheters and Hemodialysis (2 papers). The work is most often cited by research in Emergency Medical Services (65 citations), Otorhinolaryngology (39 citations), Pharmacology (83 citations), Rheumatology (92 citations) and Hematology (65 citations). C McLeod has collaborated with scholars based in United Kingdom, United States and Qatar. Frequent co-authors include Y Dündar, Angela Boland, A Bagust, Rumona Dickson, T Walley, Nigel Fleeman, J Greenhalgh, Ruaraidh Hill, Rubén Mújica-Mota and Munir Pirmohamed. Their work appears in journals such as Health Technology Assessment, Journal of Clinical Apheresis, PharmacoEconomics, Primary Health Care Research & Development and The Pharmacogenomics Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.